Chronic stress exposure represents one of the most pervasive challenges to modern public health a disabling condition that profoundly disrupts neurophysiological regulation and manifests in emotional, cognitive, and somatic domains. Although not classified as a distinct disorder in the DSM-5, its effects on brain plasticity and functional connectivity are well-documented. In this context, non-invasive neuromodulation techniques are emerging as therapeutic tools of great potential.

This article delves into the findings of a retrospective study published in Cureus, which analyzed the effects of REAC (Radio Electric Asymmetric Conveyer) Neuromodulation with the BWO-G (Brain Wave Optimization Gamma) protocol on individuals with chronic stress exposure. We will explore the protocols, mechanisms of action, and scientific evidence supporting this technology as a targeted strategy to promote functional brain reorganization and restore neuro-psycho-physical balance.

Therapeutic Protocols and Goals of REAC Treatments

REAC technology is based on a family of neuro-psycho-physical optimization protocols. The specific protocol used in this study, REAC BWO-G, is part of the NPPO-CB (Neuro Psycho Physical Optimization – Cervico Brachial) family of protocols.

The primary objective of the treatment is to interact with brain areas where endogenous bioelectrical activity has been altered by epigenetic processes, such as those induced by chronic stress. The term Brain Wave Optimization (BWO) indicates the therapeutic focus on restoring the balanced generation of endogenous brain rhythms (delta, theta, alpha, beta, and gamma waves).

The Gamma (G) suffix emphasizes that this specific protocol is designed to facilitate the recovery of optimal gamma wave activity (>30 Hz). These brainwaves are essential for higher-order integrative functions, such as attention, memory, and consciousness, which are often compromised in states of chronic stress and other dysregulated conditions.

Mechanisms of Action: How REAC Technology Works

Unlike other neuromodulation techniques such as TMS (Transcranial Magnetic Stimulation) or tDCS (Transcranial Direct Current Stimulation), REAC technology does not deliver direct currents or pulses into tissues. Its mechanism is based on the interaction between very low-intensity radioelectric fields, conveyed asymmetrically, and the endogenous bioelectrical activity of the target areas.

The process can be described as follows:

1. Asymmetric Emission: The medical device (BENE Mod 110) generates a low-intensity radioelectric field, comparable to everyday environmental exposure. This field is administered via asymmetric conveyor probes (ACPs) placed bilaterally over the cervico-brachial area.
2. Interaction and Optimization: The field interacts with areas of altered bioelectrical activity, promoting their progressive normalization. It does not “force” neuronal activity but rather “guides” the recovery of functional neurophysiological patterns.
3. Standardization and Safety: The emission parameters (intensity, waveform, duration) are pre-set by the manufacturer and cannot be modified by the operator. This ensures the standardization and reproducibility of the treatment, eliminating operator-dependent variables.

The sessions, each lasting approximately five minutes, are entirely non-invasive, and patients report no subjective perception of the treatment. No adverse effects were reported in the study.

Expected Outcomes and Scientific Evidence

The retrospective study analyzed five cases of individuals exposed to chronic occupational stress who underwent 18 sessions of REAC BWO-G. Pre- and post-treatment evaluations, conducted using quantitative electroencephalography (qEEG), Independent Component Analysis (ICA), and standardized low-resolution brain electromagnetic tomography (sLORETA), revealed consistent and significant trends.

At the neurophysiological level, the main findings include:

• Increased Power Symmetry: An increase in symmetry was observed in the delta, theta, and alpha frequency bands, indicating improved cortical synchronization.
• Reorganization of Cortical Activity: Dominant activity shifted towards areas associated with emotional regulation and the Default Mode Network (DMN), such as the posterior cingulate cortex and the retrosplenial cortex.
• Normalization of Hyperactivity: Areas that showed hyperactivity before treatment (with Z-scores >2.5) demonstrated a normalization of values after the therapy cycle (Z-scores <1.5).

At the clinical level, all participants reported significant improvements in:

• Emotional stability.
• Sleep quality.
• Cognitive clarity.

These clinical outcomes, corroborated by medical personnel, align perfectly with the observed neurophysiological changes, suggesting that REAC BWO-G treatment facilitates a rebalancing of the dysfunctional cortical dynamics induced by chronic stress.

Integration with Other REAC Treatments

The BWO-G protocol is one of the tools available within the broader REAC therapeutic platform. In a personalized clinical pathway, it can be integrated with or preceded by other neuro-optimization protocols to address different facets of neuro-psycho-physical dysregulation, acting on multiple levels for a more complete and stable functional recovery.

Conclusion and Future Perspectives

REAC BWO-G neuromodulation is emerging as a non-invasive, safe, and promising therapeutic strategy for promoting functional brain reorganization in individuals suffering from chronic stress-related dysregulation. The integration of advanced neurophysiological analyses like qEEG and sLORETA provides an objective framework for monitoring treatment effects, validating the clinical improvements reported by patients.

The data from the study indicate the reproducibility of its effects and underscore the significant potential of this intervention for stress-related dysregulation. The ability to modulate endogenous bioelectrical activity, rather than imposing it externally, represents a paradigm shift in the approach to neuromodulation, paving the way for increasingly targeted and physiological interventions.

For medical and psychology professionals who wish to explore the potential of REAC neuromodulation and its clinical applications, we invite you to contact us to receive detailed scientific documentation and discuss potential training and collaboration opportunities.

Reference: Rinaldi S, Oliveira AS, Modestto V, et al. (August 25, 2025) Functional Brain Reorganization After Radio Electric Asymmetric Conveyer (REAC) Brain Wave Optimization Gamma (BWO-G) Neuromodulation in Individuals With Chronic Stress Exposure: A Retrospective Case Series With Multimodal Evaluation. Cureus 17(8): e90951. DOI 10.7759/cureus.90951

Read the full study: https://pmc.ncbi.nlm.nih.gov/articles/PMC12377494/